A new ISO standard that helps assess the sustainability of products and processes related to bioenergy has a huge potential to tackle climate change, promote energy security and foster sustainable development.
Minneapolis Heart Institute Foundation. Summary: Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, according to new research. Share:
Many factors, including other health problems or advanced age, can affect your prognosis. On average, patients live about 2 to 5 years after they have been diagnosed. Some people with IPF live for 10 or more years following their diagnosis, while others experience a rapid decline in health.